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Abstract
Psychoneuroimmunology is a study that investigates the interaction between 
human emotions and the immune system, which is mediated by the endocrine 
and nervous systems. The nervous and immune systems maintain extensive 
communication, including communication to lymphoid organs from deep-rooted 
sympathetic and parasympathetic nerves. Genetic factors are responsible for 
individual variation in emotional reactivity, and neuroendocrine stress responses 
were shown by earlier studies in humans. Several gene-environment studies have 
shown that long-term effects of stress are being moderated by genetic variations 
in the hypothalamic-pituitary-adrenal (HPA) axis. There is a large interindi-
vidual variability of HPA axis stress reactivity on variants of the glucocorticoid 
(GR) or mineralocorticoid receptor genes, and it documents a sex-specific 
association between different GR gene polymorphisms and salivary cortisol 
responses to acute psychosocial stress. In conclusion, many kinds of mind-body 
behavioral interventions are effective in improving mood, quality of life, reduc-
ing stress, and anxiety, thereby altering neuroendocrine and immune functions, 
and ultimately altering the genetic aberrations. However, the question remains 
as to whether these latter effects are sufficiently large or last long enough to 
contribute to health benefits, or if they are even relevant to the development of a 
disease.
Keywords: psychoneuroimmunology, immunology and genetics, emotional stress, 
genetic factors involved in stress, epigenetics involved in stress
1. Psychoneuroimmunology
Psychoneuroimmunology is an area that examines the interaction between 
human emotions and the immune system, which is mediated by the endocrine and 
nervous system. The brain controls the immune system by hardwiring sympathetic 
and parasympathetic nerves to lymphoid organs. Further neuroendocrine hor-
mones such as a corticotropin-releasing hormone or substance P regulate cytokine 
balance. The immune system controls some brain activities such as sleep and body 
temperature. Based on anatomical and a close functional connection, the nervous 
and immune systems act in a very mutual way. Over recent decades, reasonable evi-
dence has emerged that these brain-to-immune interactions are highly modulated 
by psychological factors which influence immunity and immune system-mediated 
disease [1].
The nervous and immune systems maintain extensive communication, includ-
ing communication to lymphoid organs from deep-rooted sympathetic and 
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parasympathetic nerves. Acetylcholine, norepinephrine, vasoactive intestinal 
peptide, substance P, and histamine such as neurotransmitters modulate immune 
activity. Corticotropin-releasing factor, leptin, and alpha-melanocyte-stimulating 
hormone such neuroendocrine hormones regulate cytokine balance. The brain 
activity mainly body temperature, sleep, and feeding behavior is influenced by the 
immune system. The major histocompatibility complex directs T cells to immu-
nogenic molecules held in its cleft and also controls the development of neuronal 
connections. Neurobiologists and immunologists are exploring common ideas like 
the synapse to understand properties such as memory which is shared between 
these two systems [2].
Both neuronal (direct sympathetic innervation of the lymphoid organ) and 
neuroendocrine (hypothalamic-pituitary-adrenal axis) pathways are involved 
in the control of the humoral and cellular immune responses. There is a recent 
evidence on the immunosuppressive effect of acetylcholine-secreting neurons of 
the parasympathetic nervous system which influences the central nervous system 
primarily through cytokines. Neuroimmune signal molecules such as hormones, 
neurotransmitters, neuropeptides, cytokines, or their receptors enable mutual 
neuroimmune communication. Subcellular and molecular mechanisms of cyto-
kine-neuropeptide/neurotransmitter interactions were extensively investigated. 
At the neuroanatomical level, neuroimmune communication in the role of discrete 
brain areas related to emotionality has been established. Immuno-enhancement, 
including the antitumor cytotoxic activity and antiviral activity, related to the 
“brain reward system,” limbic structures, and neocortex, offers a new direction for 
therapy in immune disorders [3].
2. Immunology and genetics
Genetic predisposition is important for this immune function. Stress-mediated 
inflammation is a common feature of many hereditary disorders, due to the proteo-
toxic effects of mutant proteins. Harmful mutant proteins can induce dysregulated 
IL-1β production and inflammation. Depressive disorders are often accompanied by 
profound changes in immunity. Clinical observations in depression disorders showed 
that immune dysfunction is the main cause of increased risks in other oncological, 
inflammatory, and infectious diseases. Immunological reactions in psychoemotional 
stress play an important role. Studying Antidepressant-Sensitive Catalepsy (ASC) 
in mice showed a decrease in IgM immune responses and sensitivity to the admin-
istration of antidepressants. Unlike their non-depressive parental CBA strains, ASC 
lines show the difference in T-lymphocyte distribution and changes in IgG and IgM 
immune responses, low antibody production, abnormal CD4+ T-cell content in 
blood and spleen, and variations in CD4+/CD8+ T-cell ratio [4].
Stress-induced inflammation is a key pathogenic factor in inherited diseases and 
autoinflammatory syndromes. The stress contributes severity of the symptoms in 
these diseases. A study showed the correlation among basal stress, disease severity, 
and antioxidant response in two different cryopyrin-associated periodic syndrome 
(CAPS) patients sharing same nucleotide-binding domain, leucine-rich-containing 
family, pyrin domain-containing 3 (NLRP3) mutation [5]. Hence, similar stress-
related mechanisms may operate in other genetic diseases, where inflammation 
causes disease progression and mutant protein present in monocytes. Improving the 
responses to stress represents a promising therapeutic opportunity for this kind of 
serious diseases, while considering the genetic factor (individual tolerance levels) 
may play a major role.
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3. Molecular mechanisms of emotional stress
Identification of mechanisms underlying a dysregulation of major components 
of the stress response system is a very challenging task as it involves complex 
cellular interactions at the level of different organs and systems. One of the main 
features of the stress response is the activation of the hypothalamic-pituitary-
adrenal axis (HPA) [6]. The main regions of the brain that shows stress response 
are hippocampus, amygdala, and prefrontal cortex. Decreased activity and neuro-
nal atrophy in the hippocampus and in the prefrontal cortex, as well as increased 
activity and neuronal growth in the amygdala, are involved in post-traumatic 
stress disorder (PTSD) [6]. The changes that stress induces mainly affect the 
levels of cortisol and catecholamines (epinephrine, norepinephrine, dopamine). 
Catecholamines are released shortly after stress onset and go back to normal 
levels upon stress termination. Glucocorticoids act by binding to two types of 
receptors—mineralocorticoid receptors (MR) and glucocorticoid receptors (GR). 
Molecular mechanisms involving this stress response are genetic, epigenetic, and 
immunological nature.
4. Hormonal and immunological factors in stress response
The primary hormonal end product of the HPA axis is cortisol. A longitudinal 
study of 358 Dutch adolescents with a mean age of 15 years over 3 years showed that 
cortisol awakening response (CAR) moderated the effects of depressive symptoms 
on violent adult outcomes. The results showed that depressive symptoms were 
positively associated with violent outcomes when CAR levels are low [7].
Mental and physical stress can suppress the immune system in both humans 
and animals. Chronic stress-induced alterations in immune responses could 
result from increased cell death and apoptosis or decreased cell proliferation. It 
is well known that exhausting physical activity and mental stress lead to immu-
nosuppression of the immune system by steroid hormone regulation. Chronic 
stress significantly enhances corticosterone production and induces lymphocyte 
apoptosis [8, 9]. Stress hormones like cortisol play a fundamental role in regulat-
ing immune responses and the balance of T helper (Th) 1 and Th2 cytokines, 
thereby modulating the susceptibility of various immune-related disorders. 
Toll-like receptors (TLRs) play a key role in modulating immune responses, cell 
apoptosis, and cell survival. Among 11 known TLRs in mammals, TLR9 plays a 
major role in chronic stress-induced immune suppression by modulating cortico-
steroid levels [10].
Psychosocial stressors increase peripheral cytokine production, a potentially 
important factor in the development of depression or anxiety [11, 12]. Subsets 
of patients with the major depressive disorder (MDD) and post-traumatic stress 
disorder have higher levels of multiple inflammatory markers, including the 
cytokine interleukin 6 (IL-6) [11, 13]. Preexisting differences in the sensitivity of 
an individual’s peripheral immune system like cytokine interleukin 6 (IL-6) dictates 
their subsequent vulnerability or resilience to social stress [14].
5. Genetic factors involved in stress
Molecular studies of the stress phenomenon have found some genes which 
are differentially expressed in stressed individuals and control subjects. Studies 
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involving effect at individual genes as well as genome-wide studies at cellular, tis-
sue, and individual levels are reported.
A study of DNA microarray from circulating leucocytes showed that the 
stress causes some genes upregulated and some other genes downregulated. The 
downregulated genes are mainly related to apoptosis, cell cycle inhibitors, NF-KB 
inhibitor (Apo J), and antiproliferative cytokines. The upregulated genes are 
involved in cell cycle activation, and enzymes involved in nucleic acid biosynthe-
sis and proteins. Other upregulated genes are transcription factors that control 
chromatin structure and cell growth [15]. The transcription factor that controls 
many of these genes is NF-KB. Hence, NF-KB plays a key role in the cellular stress 
response.
Researchers have attempted to attribute genetic variation among individuals to 
their neuroendocrine responsiveness to environmental stimuli like stress by study-
ing how the immune system interacts with the nervous and endocrine systems and, 
together, how they impact upon the course and outcome of disease [16]. As early as 
1992, Gatz et al. studied the importance of genes and environments on the symp-
toms of depression [17].
Genetic factors are responsible for individual variation in emotional reactivity, 
and neuroendocrine stress responses were shown by family and twin studies in 
humans and by the study of inbred strains and selection experiments in animals 
[18]. A twin study revealed the significant genetic impact on the cortisol awak-
ening response with heritability estimates between 0.40 and 0.48 for the mean 
cortisol increase after awakening and the area under the curve, respectively [19]. 
An increased cortisol awakening response in individuals reporting chronic stress 
includes social stress and lack of social recognition [19].
Several gene-environment studies have shown that long-term effects of stress 
are being moderated by genetic variations in the hypothalamic-pituitary-adrenal 
(HPA) axis. Studies by Wust et al. investigated contribution of large interindi-
vidual variability of HPA axis stress reactivity on variants of the glucocorticoid 
or mineralocorticoid receptor genes and documented a sex-specific association 
between different GR gene polymorphisms and salivary cortisol responses to acute 
psychosocial stress [20]. Single-nucleotide polymorphisms (SNPs) associated with 
stress vulnerability and resilience are found in the GR (e.g., through regulation by 
the FK506 binding protein 5 [FKBP5]), the corticotropin-releasing hormone factor 
receptor 1 (CRHR1), and the MR genes [21].
The genetic component is often complex in these studies and involves several 
genes and, hence, should study the quantitative trait loci (QTL). It is easy to study 
QTL in plants and animals where you can easily get the inbred lines where the 
genetic makeup is similar among individuals. Quantitative genetic analysis to 
behavioral responses to environmental challenges like stress in humans is done 
mainly on the large cohorts of families and twins.
Another approach is the utilization of genome-wide association studies 
(GWAS) that would facilitate identification of new genes involved in stress 
development and elucidate the molecular pathways which are dysregulated. In 
contrast to candidate gene studies that are based on prior biological knowledge, 
in GWASs common variants across the whole genome are screened concerning 
the contributing genes. GWASs for human stress-related phenotypes are rare 
[21]. A meta-analysis on plasma cortisol levels in 12,597 participants found a 
genome-wide association of SNPs in the SERPINA6/SERPINA1 locus. GWAS 
and individual gene studies are often underpowered owing to smaller sample 
sizes. There is a need to test whether the identified candidate genes appear to be 
nominally significant in the GWASs in larger samples [21].
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6. Epigenetics involved in stress
Even though genome is the blueprint for biological activity, the epigenome 
adds another layer on top of the genome and serves to modulate gene expression 
in response to environmental cues. Epigenetic modification induced by environ-
mental factors could influence the development of chronic pain by modulating 
genomic expression of one or more biological systems associated with pain and 
psychological stressors. Recent studies demonstrate that adverse psychosocial 
environments like stress can affect gene expression by altering the epigenetic 
pattern of DNA methylation, chromatin structure by histone modifications, and 
noncoding RNA expression [22].
Most of the epigenetic studies employ animal models at early life experiences 
that demonstrate epigenetic modification that occurs in response to stressors, which 
alter the developing epigenome in the hippocampus. Some studies evaluate epigen-
etic modification using adult models of stress and depression as well as consider-
ation of the role of epigenetics in resilient versus susceptible phenotypes. Adverse 
events such as stress or maltreatment at early stages of development can more read-
ily trigger epigenetic alterations which can adversely affect physiological function 
and behavior in adult life. Studies involving human samples from different models 
like suicide victims with and without child abuse, prenatal depression, and post-
traumatic stress disorder showed altered DNA methylation patterns at the gluco-
corticoid receptor gene (NR3C1) [22]. The salivary cortisol response which in turn 
leads to altered central regulation of the HPA axis consequent to maternal depressed 
mood. Epigenetic changes due to stress affected the gene expression of several 
genes including estrogen receptor alpha (ER-A), trichostatin (TSA), N-methyl-d-
aspartate (NMDA), nerve growth factor-inducible protein-A (NGFI-A), arginine 
vasopressin (AVP), brain-derived neurotrophic factor (BDNF), and cyclic-AMP 
response element-binding protein (CREB) [22]. Telomere shortening is one of the 
molecular indicators as an epigenetic effect on stress and chronic pain [23].
7. Biomarkers for diagnosis and treatment of stress
The hypothalamus-pituitary-adrenal axis (HPA axis) is a vital part of the 
human stress response system. The endocrine marker cortisol is a useful index 
of HPA axis activity, and it shows good intraindividual stability across time and 
appears to uncover subtle changes in HPA regulation. Cortisol activity and the 
response are important biological indicators of emotional and behavioral responses 
to environmental stressors. Low cortisol activity is hypothesized to be linked to 
antisocial behaviors [24]. Several studies demonstrated the role of age and gender; 
endogenous and exogenous sex steroid levels; pregnancy, lactation, and breastfeed-
ing; smoking, coffee, and alcohol consumption; as well as dietary energy supply in 
salivary cortisol responses to acute stress [25]. Salivary cortisol levels are a reliable 
measure of HPA axis adaptation to stress and hence are a useful and valid biomarker 
in stress research [26].
The knowledge of the molecular bases of genetic variability points to the 
biochemical pathways responsible for the differences in stress responses will allow 
the development of new therapeutic strategies for pathological conditions [18]. 
Interventions aimed at manipulating the epigenome are a real and promising 
possibility to circumvent the stress-related psychoneuroimmunology disorders. 
Epigenetic and telomere changes may offer an array of targets that can be exploited 
for prevention and treatment interventions [27].
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In conclusion, many kinds of mind-body behavioral interventions are effective 
in improving mood, quality of life, reducing stress, and anxiety, thereby altering 
neuroendocrine and immune functions, and ultimately altering the genetic aber-
rations. However, the question remains as to whether these latter effects are suf-
ficiently large or last long enough to contribute to health benefits or if they are even 
relevant to the development of a disease. Unfortunately, there is no strong body of 
evidence that supports the clinical correlation between psychoneuroimmunology 
and genetics and reaping the health benefits through behavioral interventions.
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